Grunenthal (Branded Product Portfolio)

Grunenthal (Branded Product Portfolio) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Grunenthal (Branded Product Portfolio) General Information

Description

14 own and licensed brands in Eastern Europe and the Middle East. The products include Tramal, Zaldiar, Transtec and Palexia currently sold in the contract area in Russia, Bosnia, Latvia, Estonia, Saudi Arabia, Kuwait, Lebanon, Jordan, the United Arab Emirates, Egypt, Yemen, Oman, Bahrain and Qatar.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Grunenthal (Branded Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request a free trial

Grunenthal (Branded Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request a free trial